Atlas Trials

Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)

Clinical trial NCT02389933 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT02389933
Sponsor
Novartis Pharmaceuticals
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Heart Failure With Reduced Ejection Fraction (HF-rEF)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.